Nirogaya Pharmaceuticals Private Limited
About Nirogaya Pharmaceuticals Private Limited
Data last updated:
Nirogaya Pharmaceuticals Private Limited is a private limited company based in Jalandhar, Punjab, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 10 January 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB2014PTC038279. Its GSTIN is 03AAFCN1484R1Z1 (Punjab).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Asheesh Kapoor (Managing Director) and Navneet Kapoor.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 77 Vijay Nagar, Jalandhar, Punjab, India – 144001.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nirogaya Pharmaceuticals Private Limited's registered office is in Jalandhar, Punjab. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address77 Vijay Nagar, Jalandhar, Punjab, India – 144001
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Nirogaya Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nirogaya Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
Financials of Nirogaya Pharmaceuticals Private Limited
FY 2025 filings availableNirogaya Pharmaceuticals Private Limited reported revenue of ₹1,646 (down 96% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 76% over five years, including a 96% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nirogaya Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nirogaya Pharmaceuticals Private Limited
Nirogaya Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Asheesh Kapoor Also directs: Hakim Tilak Raj Kapoor Hospital Private Limited | Managing Director | 10 Jan 2014 | 12 Years 9 Months | Current |
| Navneet Kapoor Also directs: Hakim Tilak Raj Kapoor Hospital Private Limited | Director | 04 Jun 2014 | 12 Years 5 Months | Current |
Auditor
Nirogaya Pharmaceuticals Private Limited is audited by SURINDER MAHAJAN & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SURINDER MAHAJAN & ASSOCIATES | FY 2017 | 009973N |
Shareholding
The shareholding of Nirogaya Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Nirogaya Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nirogaya Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nirogaya Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nirogaya Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAFCN1484R1Z1 | Punjab | Active | 19 Feb 2019 |
To see the full GST registrations and return filing status of Nirogaya Pharmaceuticals Private Limited, buy the company report.
Recent activity
Nirogaya Pharmaceuticals Private Limited has 4 board changes on record since 2014: 3 appointments and 1 cessation. The latest: Harish Kapoor ceased to be Managing Director on 06 Jun 2014.
Frequently asked questions
Nirogaya Pharmaceuticals is an active private limited company based in Jalandhar, Punjab, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 10 January 2014 (12+ years old) and is registered under CIN U24232PB2014PTC038279.
Nirogaya Pharmaceuticals has 2 current directors:
- Asheesh Kapoor - Managing Director
- Navneet Kapoor - Director
The latest financial statements of Nirogaya Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nirogaya Pharmaceuticals is 03AAFCN1484R1Z1, registered in Punjab.
The CIN (Corporate Identification Number) of Nirogaya Pharmaceuticals is U24232PB2014PTC038279. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nirogaya Pharmaceuticals was incorporated on 10 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Chandigarh.
Harish Kapoor ceased to be Managing Director on 06 Jun 2014. Navneet Kapoor was appointed as Director on 04 Jun 2014. Asheesh Kapoor was appointed as Managing Director on 10 Jan 2014. Nirogaya Pharmaceuticals has 4 board changes on record in total.
The registered office of Nirogaya Pharmaceuticals is at 77 Vijay Nagar, Jalandhar, Punjab, India – 144001.
Nirogaya Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
The compliance status of Nirogaya Pharmaceuticals is compliant as of 24 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
